The 200 per cent growth in FDI in pharmaceutical sector during 2020-21 has been followed by a 53 per cent rise during April-September 2021-22, mainly on account of the COVID-19 pandemic.
As Union Finance Minister Nirmala Sitharaman is scheduled to present Union Budget 2022 on February 1, the healthcare and diagnostics sector has pinned hope of an increase in the allocation in view of the pandemic that has been full of transitions. Health, at present, has become the biggest priority for people and nations alike. In India, the pandemic exposed several gaps in the existing healthcare infrastructure. However, the government has been quick to come up with reforms and policy levels
Molnupiravir, the world’s first and only oral antiviral to be approved by the US FDA, UK MHRA and Indian CDSCO for treatment of COVID-19 (emergency restricted use), is set for a launch. The drug will be launched by ENTOD Pharmaceuticals. The company confirmed the launch of the generic version of Mol